Академический Документы
Профессиональный Документы
Культура Документы
2014
1.
27.08.201
4
2.
27.08.20
14
3.
4.
5.
6.
7.
"To
improve
glycemic
control in combination with
other
glucose
lowering
medicinal
products
including
insulin
when
these together with diet
and
exercise,
do
not
provide adequate glycemic
control or as monotherapy
as adjunct to diet and
exercise
to
improve
glycemic control in adults
aged 18 years or older with
type 2 Diabetic mellitus."
For
the
maintenance
treatment
of
severe
chronic
obstructive
pulmonary disease (COPD)
(FEV1 post-bronchodilator
less than 50% predicted)
associated with chronic
bronchitis in adult patients
with a history of frequent
exacerbations as add on to
bronchodilator treatment.
For the treatment of
patients with metastatic
colorectal cancer (CRC)
who have been previously
treated
with
fluoropyrimidine,
oxaliplatin and irinotecanbase
chemotherapy,
ananti-VEGF therapy, and,
if KRAS wild type, an antiEGFR therapy.
For the treatment of adult
patients with all subtypes of
Myelodysplastic Syndrome
For treatment of patients with
Asthma and COPD without
17.07.20
14
01.07.201
4
29.04.201
4
29.04.14
24.04.14
8.
9.
10.
11.
12.
13.
14.
15.
16.
co-morbidity
Pegaspargase Injection 3,750 IU/5
Indicated as a component of
multi agent
mL
chemotherapeutic regimen
for the treatment of
patients with acute
lymphoblastic leukemia who
are hypersensitive to
asparaginase
Tolterodine Tartrate Extended
For the treatment of
release tablets 2mg/4mg
overactive bladder with
(Additional Dosage Form)
symptoms of urge urinary
incontinence, urinary
incontinence, urgency and
frequency
Bortezomib for injection 3.5mg Same as already approved
(Sub-cutaneous route of
administration as an alternate
to intravenous route)
(Additional route of
administration)
Paclitaxel Injection Concentrate For the treatment of Breast
for Nanodispersion 100mg and
cancer after failure of
300mg
combination therapy
(Additional Dosage Form)
metastatic disease or relapse
within six months of adjuvant
chemotherapy. Prior therapy
should have included an
anthracycline unless clinically
contraindicated
Heparin Sodium Topical
For the management of post
Solution 1000 IU/ml (Additional infusion superficial
Dosage Form)
thrombophlebitis.
Simethicone Orally
disintegrating strip 62.5mg
Flatulance and as adjuvant in
(Additional Dosage Form)
hyperacidity.
As add on therapy in mild to
moderate
asthma
inadequately controlled by
Montelukast sodium chewable
inhaled corticosteroids and
tablet 4mg/5mg and
short active B2 agonist,
Montelukast sodium film
Exercise
induced
coated tablet 10mg.
bronchoconstriction.
Indicated in patients with
chronic hepatitis C Virus
(HCV)
infection
for
the
treatment
of
thrombocytopenia to: Enable
the initiation of interferon
Eltrombopag Olamine tablet
based
therapy,
optimise
25/50mg (Additional Indication) interferon based therapy.
Decitabine lyophilised powder
For the treatment of adult
for injection 50mg/20ml vial
patients aged 65 years and
07.03.14
31.01.14
28.01.14
22.01.201
4
16.01.201
4
14.11.201
0
26.02.200
2
07.04.201
4
09.04.201
4
(Additional indication)
Glycopyrronium bromide
inhalation powder hard capsule
with inhaler. Each capsule
contains 63mcg
17. Glycopyrronium bromide eq. to
Glycopyrronium 50 mcg.
19.
01.04.201
4
2.05.2014
16.05.201
4
21.05.201
4
17.06.201
22.
23.
24.
25.
pathological sequelae
aprosexia in dementia.
and
02.07.201
4